Publication | Open Access

Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancer

Advanced Breast CancerBreast OncologyOncologyHigh-dose Retinyl AcetateMedicinePhase Ii StudyBreast CancerPharmacotherapyCancer TreatmentPharmacologyRadiation OncologyEndocrine-related Cancer